XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 44.53

Change

-0.10 (-0.22)%

Market Cap

CAD 0.55B

Volume

892.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-13 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.03 (-0.02%)

CAD 20.69B
ZSP:CA BMO S&P 500

-0.05 (-0.05%)

CAD 18.86B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.11 (+0.18%)

CAD 11.36B
VUN:CA Vanguard US Total Market

-0.02 (-0.02%)

CAD 11.07B
XUS:CA iShares Core S&P 500 Index ETF

-0.01 (-0.02%)

CAD 8.43B
HXS:CA Global X S&P 500 Corporate Cla..

-0.03 (-0.03%)

CAD 4.68B
VSP:CA Vanguard S&P 500 CAD hedged

+0.12 (+0.13%)

CAD 4.03B
QUU:CA Mackenzie US Large Cap Equity ..

-0.75 (-0.31%)

CAD 3.48B
XUU:CA iShares Core S&P US Total Mark..

-0.07 (-0.11%)

CAD 3.43B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-0.20 (-0.38%)

CAD 3.26B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.85% 48% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.85% 48% F 42% F
Trailing 12 Months  
Capital Gain 30.89% 88% B+ 85% B
Dividend Return 1.09% 28% F 12% F
Total Return 31.98% 93% A 85% B
Trailing 5 Years  
Capital Gain 93.95% 77% C+ 87% B+
Dividend Return 6.80% 17% F 12% F
Total Return 100.74% 75% C 85% B
Average Annual (5 Year Horizon)  
Capital Gain 15.02% 76% C+ 79% B-
Dividend Return 15.88% 73% C 76% C+
Total Return 0.85% 23% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 15.54% 37% F 55% F
Risk Adjusted Return 102.15% 64% D 95% A
Market Capitalization 0.55B 53% F 60% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.